ATE223397T1 - Verfahren zu herstellung von simvastatin und zwischenprodukten - Google Patents

Verfahren zu herstellung von simvastatin und zwischenprodukten

Info

Publication number
ATE223397T1
ATE223397T1 AT99924627T AT99924627T ATE223397T1 AT E223397 T1 ATE223397 T1 AT E223397T1 AT 99924627 T AT99924627 T AT 99924627T AT 99924627 T AT99924627 T AT 99924627T AT E223397 T1 ATE223397 T1 AT E223397T1
Authority
AT
Austria
Prior art keywords
intermediate products
simvastatin
producing simvastatin
lovastatin
producing
Prior art date
Application number
AT99924627T
Other languages
English (en)
Inventor
Khashayar Karimian
Tim Fat Tam
Yong Tao
Yiwei Li
Gary Doucette
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Application granted granted Critical
Publication of ATE223397T1 publication Critical patent/ATE223397T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99924627T 1998-06-18 1999-06-10 Verfahren zu herstellung von simvastatin und zwischenprodukten ATE223397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002240983A CA2240983A1 (en) 1998-06-18 1998-06-18 Process to manufacture simvastatin and intermediates
PCT/CA1999/000540 WO1999065892A1 (en) 1998-06-18 1999-06-10 Process to manufacture simvastatin and intermediates

Publications (1)

Publication Number Publication Date
ATE223397T1 true ATE223397T1 (de) 2002-09-15

Family

ID=4162564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924627T ATE223397T1 (de) 1998-06-18 1999-06-10 Verfahren zu herstellung von simvastatin und zwischenprodukten

Country Status (7)

Country Link
US (1) US6506929B1 (de)
EP (1) EP1087958B1 (de)
AT (1) ATE223397T1 (de)
CA (1) CA2240983A1 (de)
DE (1) DE69902788T2 (de)
ES (1) ES2183559T3 (de)
WO (1) WO1999065892A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940395A1 (de) * 1998-03-05 1999-09-08 Synthon B.V. Verfahren zur Erzeugung von Simvatarin in und/oder deren Derivate
KR100435142B1 (ko) * 2002-01-09 2004-06-09 한미약품 주식회사 개선된 심바스타틴의 제조방법
AU2003289546A1 (en) * 2003-12-16 2005-07-05 Uk Chemipharm Co., Ltd. Process for preparing simvastatin.
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
PL2018153T3 (pl) * 2006-04-26 2012-09-28 Rosemont Pharmaceuticals Ltd Ciekłe kompozycje doustne
CN103254076A (zh) * 2008-05-09 2013-08-21 上海医药工业研究院 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU548996B2 (en) 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4450171A (en) 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3480923D1 (de) * 1983-10-11 1990-02-08 Merck & Co Inc Verfahren zur c-methylierung von 2-methylbutyraten.
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US4916239A (en) 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
US5072002A (en) * 1989-07-18 1991-12-10 The Governors Of The University Of Alberta Synthesis of cholesterol-lowering agents
US5223415A (en) 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
US5159104A (en) 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
DE69902788D1 (de) 2002-10-10
EP1087958A1 (de) 2001-04-04
WO1999065892A1 (en) 1999-12-23
ES2183559T3 (es) 2003-03-16
EP1087958B1 (de) 2002-09-04
US6506929B1 (en) 2003-01-14
CA2240983A1 (en) 1999-12-18
DE69902788T2 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
EP1589017A3 (de) 12,13-Modifizierte Epothilon-Derivate
MX201091B (es) Sisntesis de capsulas de latex.
EP0825867A4 (de) N,o-carboxymethylchitosan zur verhinderung operativ bedingter adhäsionen
HUP9601033A3 (en) Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
HUP9600114A2 (en) 2,8-disubstituted quinazolinones and pharmaceutical compositions containing them
SI0951466T1 (sl) Cikloalkili, laktami, laktoni in sorodne spojine, farmacevtske zmesi, ki jih vsebujejo, in metode inhibicije sproščanja beta-amiloidnega peptida in/ali njegove sinteze z uporabo takih spojin
DE69628582D1 (de) Selektive öffnung von 5- und 6-gliedrigen ringen
ES2090507T3 (es) Procedimiento para la preparacion de simvastatina.
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
HUP9901344A3 (en) Radicicol derivatives and pharmaceutical compositions thereof
AU8055594A (en) Process for producing simvastatin and analogs thereof
CZ129596A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE69902788D1 (de) Verfahren zu herstellung von simvastatin und zwischenprodukten
HU9600099D0 (en) Process for producing flavano-lignane compositions of improved release and absorption, compositions produced this way find use of them for producing pharmaceutical compositions
GB9515279D0 (en) Improved therapeutic agents
EP0828520A4 (de) Verfahren zum screening von verbindungen, die zur prävention von infektionen oder der pathogenität
DZ1977A1 (fr) Procédé de préparation du trihydrate du (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpro-pionate de 4,10-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1,7beta-dihydroxy-9-oxo-tax-11-en-13alpha-yle.
NO951135D0 (no) Syntese av N-acetyl-neuraminsyrederivater
FI962603A7 (fi) Hydroksihapon tai sitä sisältävän tuotteen käyttö sekä siitä tehty valmiste
NO974155L (no) Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater
FR2730166B1 (fr) Generateur d'aerosols avec moyen de sterilisation
FI956220L (fi) Alkenyylimeripihkahappoanhydridin valmistus
ES2100023T3 (es) Nuevos derivados 17,20-epoxidos del pregnano, su aplicacion a la preparacion de derivados cortisonicos y productos intermedios.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties